Cargando…
CPT1A plays a key role in the development and treatment of multiple sclerosis and experimental autoimmune encephalomyelitis
Human mutations in carnitine palmitoyl transferase 1A (CPT1A) are correlated with a remarkably low prevalence of multiple sclerosis (MS) in Inuits (P479L) and Hutterites (G710E). To elucidate the role of CPT1A, we established a Cpt1a P479L mouse strain and evaluated its sensitivity to experimental a...
Autores principales: | Mørkholt, Anne Skøttrup, Trabjerg, Michael Sloth, Oklinski, Michal Krystian Egelund, Bolther, Luise, Kroese, Lona John, Pritchard, Colin Eliot Jason, Huijbers, Ivo Johan, Nieland, John Dirk Vestergaard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746708/ https://www.ncbi.nlm.nih.gov/pubmed/31527712 http://dx.doi.org/10.1038/s41598-019-49868-6 |
Ejemplares similares
-
Dysregulation of metabolic pathways by carnitine palmitoyl-transferase 1 plays a key role in central nervous system disorders: experimental evidence based on animal models
por: Trabjerg, Michael Sloth, et al.
Publicado: (2020) -
Downregulating carnitine palmitoyl transferase 1 affects disease progression in the SOD1 G93A mouse model of ALS
por: Trabjerg, Michael Sloth, et al.
Publicado: (2021) -
Inhibition of carnitine palmitoyl-transferase 1 is a potential target in a mouse model of Parkinson’s disease
por: Trabjerg, Michael Sloth, et al.
Publicado: (2023) -
Identification of brain antigens recognized by autoantibodies in experimental autoimmune encephalomyelitis-induced animals treated with etomoxir or interferon-β
por: Mørkholt, Anne Skøttrup, et al.
Publicado: (2018) -
Pharmacological inhibition of carnitine palmitoyl transferase 1 inhibits and reverses experimental autoimmune encephalitis in rodents
por: Mørkholt, Anne Skøttrup, et al.
Publicado: (2020)